17 jan 2017 ano - FDA approved Vantrela ER (hydrocodone bitartrate extended-release tablets), an extended- release (ER) opioid analgesic to treat pain severe enough to require daily, around-the-clock, long- term opioid treatment for which alternative treatment options are inadequate. Vantrela ER is the ninth ER opioid analgesic to be approved with labeling describing the product’s abuse-deterrent properties consistent with the FDA’s 2015 guidance for industry, Abuse-Deterrent Opioids – Evaluation and Labeling. The ph
Adicionado na linha do tempo:
Data:
17 jan 2017 ano
Agora
~ 8 years and 9 months ago